Myocardial energy depletion and dynamic systolic dysfunction in hypertrophic cardiomyopathy

Julian O M Ormerod1, Michael P Frenneaux2, Mark V Sherrid3

  • 1Oxford Heart Centre, Oxford University Hospitals, Headley Way, Oxford, OX3 9DU, UK.

Insights

Hypertrophic cardiomyopathy (HCM) involves inefficient cardiomyocyte energy use. This leads to dynamic systolic dysfunction, a reversible condition that worsens with outflow obstruction, explaining unique clinical features in HCM patients.

Area of Science:

  • Cardiology
  • Molecular Cardiology
  • Genetic Cardiology

Background:

  • Hypertrophic cardiomyopathy (HCM) is linked to inefficient cardiomyocyte energy utilization and cellular energy depletion.
  • Clinical presentation of HCM often includes normal or hyperkinetic left ventricular (LV) systolic function at rest, posing a paradox to energy depletion theories.

Purpose of the Study:

  • To explore the 'lobster claw abnormality,' a reversible systolic dysfunction in obstructive HCM.
  • To propose that this abnormality, termed 'dynamic systolic dysfunction,' is a manifestation of inefficient cardiomyocyte energy utilization.

Main Methods:

  • This Perspectives article reviews existing evidence and proposes a new conceptual framework.
  • Focuses on the 'lobster claw abnormality' and its implications in obstructive HCM.

Main Results:

  • Dynamic systolic dysfunction explains mid-systolic aortic valve closure and bifid aortic pressure tracings in obstructive HCM.
  • This dysfunction underlies apical aneurysms and cardiogenic shock in some obstructive HCM cases.
  • The study posits that dynamic systolic dysfunction becomes apparent under increased afterload (obstruction) due to energy inefficiency.

Conclusions:

  • Dynamic systolic dysfunction, driven by inefficient cardiomyocyte energy use, is a key feature of HCM, particularly under obstruction.
  • This paradigm may offer insights into novel therapeutic strategies for HCM.
  • Alternative mechanisms like myofilament Ca2+ hypersensitivity and enhanced late Na+ current in HCM are also considered.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
627
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.3K
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
725
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
3.4K
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
732
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
753